0001209191-15-045635.txt : 20150521
0001209191-15-045635.hdr.sgml : 20150521
20150521185526
ACCESSION NUMBER: 0001209191-15-045635
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150519
FILED AS OF DATE: 20150521
DATE AS OF CHANGE: 20150521
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Revance Therapeutics, Inc.
CENTRAL INDEX KEY: 0001479290
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770551645
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7555 GATEWAY BLVD.
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-742-3400
MAIL ADDRESS:
STREET 1: 7555 GATEWAY BLVD.
CITY: NEWARK
STATE: CA
ZIP: 94560
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ruegg Curtis
CENTRAL INDEX KEY: 0001597578
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36297
FILM NUMBER: 15884137
MAIL ADDRESS:
STREET 1: 7555 GATEWAY BOULEVARD
CITY: NEWARK
STATE: CA
ZIP: 94560
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-05-19
0
0001479290
Revance Therapeutics, Inc.
RVNC
0001597578
Ruegg Curtis
C/O REVANCE THERAPEUTICS, INC.
7555 GATEWAY BOULEVARD
NEWARK
CA
94560
0
1
0
0
EVP, Technical Operations
Common Stock
2015-05-19
4
F
0
1310
25.94
D
18027
D
Represents the number of shares withheld by and surrendered to the Issuer on May 19, 2015, to satisfy tax withholding obligations that arose in connection with the vesting of the Restricted Stock Award ("RSA") for 10,500 shares. The RSA vests in three equal annual installments from May 19, 2014, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) on each vesting date.
/s/ Gordon Ho, Attorney-in-Fact
2015-05-21